City Research Online

Items where Subject is "RS Pharmacy and materia medica"

Up a level
Group by: Authors | Type
Jump to: Article | Monograph
Number of items at this level: 16.

Article

Ahmed, N., Giorgakoudi, K. ORCID: 0000-0002-5925-1846, Usuf, E. (2020). Potential cost-effectiveness of a maternal Group B streptococcal vaccine in The Gambia.. Vaccine, 38(15), pp. 3096-3104. doi: 10.1016/j.vaccine.2020.02.071

Bawden, D. & Robinson, L. (2011). Pharmaceutical Information: A 30-Year Perspective on the Literature. Annual Review of Information Science and Technology, 45(1), pp. 63-119. doi: 10.1002/aris.2011.1440450109

Boyd, S. E., Zhu, N., Whitney, L. (2024). Online availability of antibiotics from within the UK: shifting patterns from 2016 to 2023. Journal of Antimicrobial Chemotherapy, 79(12), pp. 3191-3198. doi: 10.1093/jac/dkae341

Charani, E., Ahmad, R. ORCID: 0000-0002-4294-7142, Rawson, T. M. (2019). The Differences in Antibiotic Decision-making Between Acute Surgical and Acute Medical Teams: An Ethnographic Study of Culture and Team Dynamics. Clinical Infectious Diseases, 69(1), pp. 12-20. doi: 10.1093/cid/ciy844

Charani, E., McKee, M., Ahmad, R. ORCID: 0000-0002-4294-7142 (2021). Optimising antimicrobial use in humans – review of current evidence and an interdisciplinary consensus on key priorities for research. Lancet Regional Health Europe, 7, article number 100161. doi: 10.1016/j.lanepe.2021.100161

Dhital, R., Sakulwach, S., Robert, G. (2022). Systematic review on the effects of the physical and social aspects of community pharmacy spaces on service users and staff. Perspectives in Public Health, 142(2), pp. 77-93. doi: 10.1177/17579139221080608

Eadie, R., McKenzie, C., Blackwood, B. (2022). Clinical pharmacist’s views on the role of alpha-2-agonists in practice and research for the management of agitation, sedation and delirium (ASD). Journal of the Intensive Care Society, 23(1), doi: 10.1177/17511437221095122

Ferriani, S. ORCID: 0000-0001-9669-3486, Lazerson, M. H. & Lorenzoni, G. (2020). Anchor entrepreneurship and industry catalysis: The rise of the Italian Biomedical Valley. Research Policy, 49(8), article number 104045. doi: 10.1016/j.respol.2020.104045

Franco, P. & Haefliger, S. ORCID: 0000-0003-4207-9207 (2025). Competition of regulatory ecosystems in approving medicines: Policy Implications in the case of Europe. Drug Discovery Today, 30(2), article number 104295. doi: 10.1016/j.drudis.2025.104295

Hills, E., Rosenberg, J., Banfield, N. (2020). A multidisciplinary approach to the implementation of non-pharmacological strategies to manage infant pain. Infant, 16(2), pp. 78-81.

Jones, A. M., Serra-Sastre, V. ORCID: 0000-0002-6329-4507 & Kim, H. (2024). The Impact of Generic Entry of Pharmaceuticals in Australia. Value in Health Regional Issues, 43, article number 101008. doi: 10.1016/j.vhri.2024.101008

Kavusan, K. & Frankort, H. T. W. ORCID: 0000-0002-0022-1570 (2019). A behavioral theory of alliance portfolio reconfiguration: Evidence from pharmaceutical biotechnology. Strategic Management Journal, 40(10), pp. 1668-1702. doi: 10.1002/smj.3041

Patton, D. E., Pearce, C. J. ORCID: 0000-0002-7393-191X, Cartwright, M. ORCID: 0000-0002-3404-5659 (2021). A non-randomised pilot study of the Solutions for Medication Adherence Problems (S-MAP) intervention in community pharmacies to support older adults adhere to multiple medications. Pilot and Feasibility Studies, 7(1), article number 18. doi: 10.1186/s40814-020-00762-3

Subramanian, A., Azcoaga-Lorenzo, A., Anand, A. (2023). Polypharmacy during pregnancy and associated risk factors: a retrospective analysis of 577 medication exposures among 1.5 million pregnancies in the UK, 2000-2019. BMC Med, 21(1), article number 21. doi: 10.1186/s12916-022-02722-5

Wiens, K. E., Lindstedt, P. A., Blacker, B. F. (2020). Mapping geographical inequalities in oral rehydration therapy coverage in low-income and middle-income countries, 2000–17. The Lancet Global Health, 8(8), e1038-e1060. doi: 10.1016/s2214-109x(20)30230-8

Monograph

Newham, M., Seldeslachts, J. & Banal-Estanol, A. (2018). Common Ownership and Market Entry: Evidence from the Pharmaceutical Industry (18/03). London, UK: Department of Economics, City, University of London.

This list was generated on Sun Mar 30 02:21:38 2025 UTC.